ETRA — Electra Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 2088082 ·
Last close
$11.55
Market Cap
—
52W High
$15.50
52W Low
$11.27
ADV30
1,356,033
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 106,498,000 | 66,507,000 | 325,953,000 |
| Dec 2025 | — | — | — | — | 99,368,000 | 33,008,000 | 262,810,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-221,890,000
Inventory
—
Receivables
$264,000
ST Investments
$31,218,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -61,889,000 | -61,975,000 | 99,368,000 | 129,694,000 | -30,326,000 | -60,484,000 |
| Dec 2024 | 0 | -26,317,000 | -24,786,000 | 19,420,000 | 122,681,000 | -103,261,000 | -26,003,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $224.15B | $414.61 | — |
| GILD | GILEAD SCIENCES, INC. | $187.15B | $150.93 | — |
| MRNA | Moderna, Inc. | $79.40B | $198.88 | — |
| ARGX | ARGENX SE | $59.67B | $959.49 | — |
| RVMD | Revolution Medicines, Inc. | $43.93B | $204.97 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-09-23 17:35:57 | 2026-09-21 | Gordon Carl L | Dir, 10% | P - Purchase | 15 | 1333333 | 19999995 |
| 2026-09-23 17:29:42 | 2026-09-21 | Orbimed Advisors LLC | Dir, 10% | P - Purchase | 15 | 1333333 | 19999995 |